Literature DB >> 16870799

A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp.

Takashi Sugita, Mami Tajima, Hisae Tsubuku, Ryoji Tsuboi, Akemi Nishikawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16870799      PMCID： PMC1538684          DOI： 10.1128/AAC.00687-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

Review 1.  Pimecrolimus 1% cream for the treatment of atopic dermatitis.

Authors:  K Wolff
Journal:  Skin Therapy Lett       Date:  2005-10

2.  Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species.

Authors:  Takashi Sugita; Mami Tajima; Tomonobu Ito; Masuyoshi Saito; Ryoji Tsuboi; Akemi Nishikawa
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.

Authors:  A K Gupta; Y Kohli; A Li; J Faergemann; R C Summerbell
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

4.  Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects.

Authors:  T Sugita; H Suto; T Unno; R Tsuboi; H Ogawa; T Shinoda; A Nishikawa
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 5.  Framing the future of antifungals in atopic dermatitis.

Authors:  Arjen F Nikkels; Gérald E Piérard
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

Review 6.  Good fungi gone bad: the corruption of calcineurin.

Authors:  Deborah S Fox; Joseph Heitman
Journal:  Bioessays       Date:  2002-10       Impact factor: 4.345

Review 7.  Atopic dermatitis and fungi.

Authors:  Jan Faergemann
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132
  7 in total
  5 in total

1.  Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment.

Authors:  Hye One Kim; Yoon Seok Yang; Hyun Chang Ko; Gyung Moon Kim; Sang Hyun Cho; Young Joon Seo; Sang Wook Son; Jong Rok Lee; Joong Sun Lee; Sung Eun Chang; Jae We Che; Chun Wook Park
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

2.  FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in Malassezia.

Authors:  Giuseppe Ianiri; Shelly Applen Clancey; Soo Chan Lee; Joseph Heitman
Journal:  MBio       Date:  2017-10-24       Impact factor: 7.867

Review 3.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813

4.  Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.

Authors:  Erica M TenBroek; Laurie Yunker; Mae Foster Nies; Alison M Bendele
Journal:  Arthritis Res Ther       Date:  2016-01-21       Impact factor: 5.156

Review 5.  Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment.

Authors:  Ditte M L Saunte; George Gaitanis; Roderick James Hay
Journal:  Front Cell Infect Microbiol       Date:  2020-03-20       Impact factor: 5.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.